CCR5 has been widely studied in HIV infection since its discovery as a co-receptor for HIV infection of target cells (Deng et al., 1996) and several CCR5 antagonists have been designed to block HIV entry into host cells. The gene discussed is CCR5; the disease is HIV infectious disease.